UBS Called Novo Nordisk a ‘Value Trap.’ Here’s the Other Side of That Argument.

Also Read

• Malaysia Shuts Schools in Kuala Lumpur and Several States Amid Worsening Haze
• TD Cowen Initiates Coverage of GS Connect S&P GSCI Enhanced Commodity Total Return ETN with Buy Rating
• Sinn Féin Under Police Investigation Over Blocked Orange March in Northern Ireland
• Ex-Chairman of Greentown China Charged in HK$20 Million Bribery Scheme